153 related articles for article (PubMed ID: 7522963)
41. Role of interleukin-6 in uncoupling of bone in vivo in a human squamous carcinoma coproducing parathyroid hormone-related peptide and interleukin-6.
Nagai Y; Yamato H; Akaogi K; Hirose K; Ueyama Y; Ikeda K; Matsumoto T; Fujita T; Ogata E
J Bone Miner Res; 1998 Apr; 13(4):664-72. PubMed ID: 9556066
[TBL] [Abstract][Full Text] [Related]
42. Prolonged and ubiquitous inhibition by interferon gamma of bone resorption induced by parathyroid hormone-related protein, 1,25-dihydroxyvitamin D3, and interleukin 1 in fetal mouse forearm bones.
Fujii Y; Sato K; Kasono K; Satoh T; Fujii T; Shizume K
Calcif Tissue Int; 1990 Sep; 47(3):178-82. PubMed ID: 2121324
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
van Breukelen FJ; Bijvoet OL; Frijlink WB; Sleeboom HP; Mulder H; van Oosterom AT
Calcif Tissue Int; 1982 Jul; 34(4):321-7. PubMed ID: 6814719
[TBL] [Abstract][Full Text] [Related]
44. [Hypocalcemic effect of elcatonin in mouse models for humoral hypercalcemia of malignancy].
Isogai Y; Hori M
Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):199-208. PubMed ID: 7774857
[TBL] [Abstract][Full Text] [Related]
45. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
Henderson J; Bernier S; D'Amour P; Goltzman D
Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
[TBL] [Abstract][Full Text] [Related]
46. Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
Rizzoli R; Buchs B; Bonjour JP
Int J Cancer; 1992 Mar; 50(5):706-12. PubMed ID: 1531972
[TBL] [Abstract][Full Text] [Related]
47. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
[TBL] [Abstract][Full Text] [Related]
48. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
49. Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
Lin JH; Chen IW; deLuna FA; Hichens M
J Pharmacol Exp Ther; 1993 Nov; 267(2):670-5. PubMed ID: 8246140
[TBL] [Abstract][Full Text] [Related]
50. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
[TBL] [Abstract][Full Text] [Related]
51. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice.
Imamura H; Sato K; Shizume K; Satoh T; Kasono K; Ozawa M; Ohmura E; Tsushima T; Demura H
J Bone Miner Res; 1991 Jan; 6(1):77-84. PubMed ID: 2048434
[TBL] [Abstract][Full Text] [Related]
52. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR
J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
[TBL] [Abstract][Full Text] [Related]
53. The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
Morony S; Warmington K; Adamu S; Asuncion F; Geng Z; Grisanti M; Tan HL; Capparelli C; Starnes C; Weimann B; Dunstan CR; Kostenuik PJ
Endocrinology; 2005 Aug; 146(8):3235-43. PubMed ID: 15845617
[TBL] [Abstract][Full Text] [Related]
54. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
55. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
Johnson RA; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1989 Mar; 124(3):1424-7. PubMed ID: 2917519
[TBL] [Abstract][Full Text] [Related]
56. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
Sabatini M; Yates AJ; Garrett IR; Chavez J; Dunn JF; Bonewald L; Mundy GR
Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
[TBL] [Abstract][Full Text] [Related]
57. Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice.
van Beek ER; Löwik CW; Papapoulos SE
Bone; 1997 Apr; 20(4):335-40. PubMed ID: 9108353
[TBL] [Abstract][Full Text] [Related]
58. Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related protein.
Michigami T; Yamato H; Mushiake S; Nakayama M; Yoneda A; Satomura K; Imura K; Ozono K
J Clin Endocrinol Metab; 1996 Mar; 81(3):1090-5. PubMed ID: 8772581
[TBL] [Abstract][Full Text] [Related]
59. The role of interleukin-6 in the induction of hypercalcemia in renal cell carcinoma transplanted into nude mice.
Weissglas MG; Schamhart DH; Löwik CW; Papapoulos SE; Theuns HM; Kurth KH
Endocrinology; 1997 May; 138(5):1879-85. PubMed ID: 9112382
[TBL] [Abstract][Full Text] [Related]
60. Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice.
Nemoto R; Sato S; Nishijima Y; Miyakawa I; Koiso K; Harada M
J Urol; 1990 Sep; 144(3):770-4. PubMed ID: 2117674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
